Suppressive effects of coumarins from Mammea siamensis on inducible nitric oxide synthase expression in RAW264.7 cells. 2012

Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
Pharmaceutical Research and Technology Institute, Kinki University, 3-4-1 Kowakae, Higashi-osaka, Osaka 577-8502, Japan.

A methanol extract of the flowers of Mammea siamensis (Calophyllaceae) was found to inhibit nitric oxide (NO) production in lipopolysaccharide-activated RAW264.7 cells. From the extract, two new geranylated coumarins, mammeasins A (1) and B (2), were isolated together with 17 known compounds including 15 coumarins. The structures of 1 and 2 were determined on the basis of their spectroscopic properties as well as of their chemical evidence. Among the isolates, 1 (IC(50) = 1.8 μM), 2 (6.4 μM), surangins B (3, 5.0 μM), C (4, 6.8 μM), and D (5, 6.2 μM), kayeassamins E (7, 6.1 μM), F (8, 6.0 μM), and G (9, 0.8 μM), mammea A/AD (11, 1.3 μM), and mammea E/BB (16, 7.9 μM) showed NO production inhibitory activity. Compounds 1, 9, and 11 were found to inhibit induction of inducible nitric oxide synthase (iNOS). With regard to mechanism of action of these active constituents (1, 9, and 11), suppression of STAT1 activation is suggested to be mainly involved in their suppression of iNOS induction.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D052247 Nitric Oxide Synthase Type II A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES. INOS Enzyme,Inducible NOS Protein,Inducible Nitric Oxide Synthase,NOS-II,Nitric Oxide Synthase II,Nitric Oxide Synthase, Type II,NOS II

Related Publications

Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
May 2002, Journal of natural products,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
November 2010, Chemical & pharmaceutical bulletin,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
January 2000, Pharmaceutical biology,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
July 2011, Journal of ethnopharmacology,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
June 2006, Chemical & pharmaceutical bulletin,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
September 2021, Molecular medicine reports,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
May 2001, Current protocols in toxicology,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
August 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
February 2002, Journal of neuroscience research,
Toshio Morikawa, and Mayumi Sueyoshi, and Saowanee Chaipech, and Hisashi Matsuda, and Yukiko Nomura, and Mikuko Yabe, and Tomoko Matsumoto, and Kiyofumi Ninomiya, and Masayuki Yoshikawa, and Yutana Pongpiriyadacha, and Takao Hayakawa, and Osamu Muraoka
October 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
Copied contents to your clipboard!